Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study
Background: Inflammatory bowel disease (IBD) is characterized by persistent inflammation and is often associated with metabolic dysfunction-associated steatotic liver disease (MASLD). IBD patients are at risk of developing MASLD due to shared risk factors such as gut dysbiosis and systemic inflammat...
Saved in:
| Main Authors: | Ludovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, Maria Luisa Gambardella, Luigi Boccuto, Nahum Méndez-Sánchez, Francesco Luzza |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-09-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/14/10/1226 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thrombotic Complications in Inflammatory Bowel Disease
by: A. V. Borota, et al.
Published: (2019-05-01) -
Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study
by: Ying-Hsiang Wang, et al.
Published: (2025-01-01) -
The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease
by: Małgorzata Woźniak, et al.
Published: (2019-03-01) -
Anemia in Inflammatory Bowel Disease: A Neglected Issue in Comprehensive Inflammatory Bowel Disease Management
by: Randy Adiwinata, et al.
Published: (2021-10-01) -
Study of Fecalibacteria prausntzii in Egyptian patients with inflammatory bowel disease
by: Khaled Abd El Atty, et al.
Published: (2024-05-01)